Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors

Journal of Leukocyte Biology

Volumn 70, Issue 4, 2001, Pages 478-490

  Crowther, M ^a   Brown, N J ^a   Bishop, E T ^a   Lewis, C E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Hypoxia; VEGF; Wound healing

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANAEROBIC METABOLISM; ANGIOGENESIS; CELL HYPOXIA; HUMAN; MACROPHAGE ACTIVATION; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION; WOUND HEALING;

ANIMALS; CELL HYPOXIA; GLUCOSE; GROWTH SUBSTANCES; HUMANS; LACTIC ACID; MACROPHAGES; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; STRESS; WOUND HEALING;

EID: 0034787977     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (188)

1. Angiogenesis
2. Mechanisms of angiogenesis
3. Mechanisms of angiogenesis and arteriogenesis
4. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
5. Endometrial microvascular growth in normal and dysfunctional states
6. Vasculogenesis
7. Embryonic angiogenesis factors
8. Angiogenesis, vascular endothelial growth factor and the endometrium
9. Integrated processes responsible for soft tissue healing
10. Pathogenesis of diabetic retinopathy
11. Angiogenesis in rheumatoid arthritis: Pathogenic and clinical significance
12. Vascular proliferation and angiogenic factors in psoriasis
13. The role of angiogenesis in tumor growth
14. How is blood vessel growth regulated in normal and neoplastic tissue?
15. Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
16. Angiogenesis: Implications for rheumatoid arthritis
17. Angiogenesis and arthritis
18. Tumor angiogenesis: Therapeutic implications
19. Angiogenesis: How a tumor adapts to hypoxia
20. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
21. The vascular endothelial growth factor family; proteins which guide the development of the vasculature
22. VEGF is required for growth and survival in neonatal mice
23. Angiogenesis and angiogenesis inhibition: An overview
24. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
25. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
26. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro
27. Extracellular matrix as a solid-state regulator in angiogenesis: Identification of new targets for anti-cancer therapy
28. Expression of basic fibroblast growth factor in normal human tissues
29. Influence of hypoxia and glucose deprivation on tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor expression in human cultured monocytes
30. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues
31. Anoxia-hyperoxia induces monocyte-derived interleukin-8
32. The clinical manipulation of angiogenesis: Pathology, side-effects, surprises, and opportunities with novel human therapies
33. Therapeutic angiogenesis
34. Cytokine networks in solid human tumors: Regulation of angiogenesis
35. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells
36. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids
37. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium
38. Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro
39. Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury
40. The biology of the macrophage
41. The macrophage as an effector cell
42. Analysis of interferon-γ-dependent and -independent pathways of macrophage activation
43. Macrophage-derived angiogenesis factors
44. Proteinases secreted by human mononuclear phagocytes
45. Contribution of monocytes/macrophages to compensatory neovascularization: The drilling of metalloelastase-positive tunnels in ischemic myocardium
46. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
47. Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages
48. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas
49. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: Association with angiogenesis and poor prognosis
50. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNF-α and IL-1α
51. The wound fibroblast and macrophage. I. Wound cell population changes observed in tissue culture
52. Macrophage phagocytosis of wound neutrophils
53. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum
54. The neutrophilic leukocyte in wound repair: A study with antineutrophil serum
55. Stimulation of wound blood vessel growth by wound macrophages
56. The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages
57. Activated macrophages induce vascular proliferation
58. Induction of neovascularization by activated human monocytes
59. Role of macrophages in wound healing
60. Early wound healing exhibits cytokine surge without evidence of hypoxia
61. Oxygen and carbon dioxide tensions in experimental wounds
62. Oxygen and carbon dioxide tensions in healing tissue
63. Colonic anastomotic healing and oxygen tension
64. Oxygen tensions in healing anastomosis of rabbit aorta
65. Oxygen tension regulates the expression of angiogenesis factor by macrophages
66. Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing
67. Monocytes and macrophages synthesize and secrete thrombospondin
68. CXC chemokines in angiogenesis
69. Chemokine and inflammatory cytokine changes during chronic wound healing
70. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
71. Lactate elicits vascular endothelial growth factor from macrophages: A possible alternative to hypoxia
72. Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages
73. Acidosis as one of the delivering factors of alveolar macrophages during suffocation
74. Anaerobic metabolism and wound healing: An hypothesis for the initiation and cessation of collagen synthesis in wounds
75. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
76. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression
77. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
78. An in vitro model of angiogenesis: Basic features
79. Macrophage content of tumours in relation to metastatic spread and host immune reaction
80. Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers
81. The cell biology of macrophage activation
82. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines
83. Secretion of epidermal growth factor by macrophages associated with breast carcinoma
84. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas
85. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages
86. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
87. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast
88. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers
89. A role for angiogenesis in rheumatoid arthritis
90. Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells
91. Basic fibroblast growth factor induces angiogenesis in vitro
92. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma
93. Angiogenic activity of fibrin degradation products is located in fibrin fragment E
94. Interactions between cancer cells and the endothelium in metastasis
95. Interleukin-8 as a macrophage-derived mediator of angiogenesis
96. Interleukin-8 stimulates angiogenesis in rats
97. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
98. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells
99. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
100. Regulation of angiogenesis by hypoxic stress: From solid tumours to the ovarian follicle
101. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
102. 2 tension measurements
103. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
104. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
105. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
106. Tumour-associated leucocytes: Friends or foes in breast carcinoma
107. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1
108. Macrophage responses to hypoxia: Relevance to disease mechanisms
109. In vivo lactate production and utilization by Jensen sarcoma and Morris hepatoma 7288CTC
110. On the origin of cancer cells
111. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts
112. Acid pH in tumors and its potential for therapeutic exploitation
113. Acidic pH enhances the invasive behavior of human melanoma cells
114. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells
115. Lipopolysaccharide impairs macrophage cytoplasmic pH regulation under conditions simulating the inflammatory microenvironment
116. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers
117. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
118. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
119. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
120. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
121. Activation of human monocytes for enhanced production of interleukin 8 during trans-endothelial migration in vitro
122. Solid tumours and wounds: Transformed cells misunderstood as injured tissue?
123. Changes in energy metabolism, structure and function in alveolar macrophages under anaerobic conditions
124. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer
125. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin
126. Purification and characterization of hypoxia-inducible factor 1
127. 2 tension
128. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells
129. Independent prognostic importance of microvessel density in endometrial carcinoma
130. 2 tension
131. The macrophage - A novel system to deliver gene therapy to pathological hypoxia
132. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
133. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
134. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3α
135. Nitrosation and oxidation in the regulation of gene expression
136. Hypoxia-associated induction of early growth response-1 gene expression
137. Regulation of macrophage eicosanoid generation is dependent on nuclear factor κB
138. Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of poly(ADP-ribose) synthesis
139. In vivo distribution of oxygen partial pressures in female breast tumors
140. Impaired wound repair and delayed angiogenesis in aged mice
141. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization
142. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
143. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
144. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer
145. Production of platelet-derived growth factor in aseptic loosening of total hip replacement
146. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer
147. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth
148. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer
149. The beneficial effect of enhanced macrophage function on the healing of bowel anastomoses
150. Expression of four growth factors during fracture repair
151. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes
152. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly
153. Wound macrophages express TGF-alpha and other growth factors in vivo: Analysis by mRNA phenotyping
154. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells
155. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer
156. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer
157. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer
158. Tumor necrosis factor and its receptors in human ovarian cancer: Potential role in disease progression
159. Cytokine production in a model of wound healing: The appearance of MIP-1, MIP-2, cachectin/TNF and IL-1
160. Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery
161. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms
162. Sinusoidal capillarization of human hepatocellular carcinoma: Possible promotion by fibroblast growth factor
163. Macrophage expression of interleukin-1 in lymphoepithelioid cell ("Lennert's") lymphoma
164. Alteration in IL-1 and arginase activity of tumor-associated macrophages: A role in the promotion of tumor growth
165. Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-gamma
166. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: Macrophages as a prominent source of interleukin-4
167. The macrophage in acute neural injury: Changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems
168. Trauma-induced alterations in macrophage function
169. Alterations in macrophage signal transduction pathways mediate post-traumatic changes in macrophage function
170. The activation of bone marrow macrophages 24 hours after thermal injury
171. Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization
172. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
173. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - A predictor of tumour stage
174. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
175. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
176. Plasminogen activation in healing human wounds
177. Thrombospondin 1 synthesis and function in wound repair
178. Gamma-interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: An immune response to human herpesvirus-8 infection?
179. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA
180. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
181. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia
182. The influence of oxygen and carbon dioxide tension on the production of TNF alpha by activated macrophages
183. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro
184. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages
185. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages
186. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects
187. Correlation of high lactate levels in head and neck tumors with incidence of metastasis
188. Respiratory gas tensions and pH in healing wounds